Next |
home / stock / mito / mito message board
Subject | By | Source | When |
---|---|---|---|
Buying more | INFINITI | investorshub | 06/09/2022 4:00:09 PM |
Agree $$$$ | INFINITI | investorshub | 06/09/2022 11:14:59 AM |
,,,,,,,THIS NEWS SHOULDA SENT THIS.70C PLUS | THEMASTERS_SON | investorshub | 06/08/2022 3:18:09 PM |
Stealth BioTherapeutics Presents New SBT-272 Data Demonstrating Improvement | INFINITI | investorshub | 06/08/2022 12:27:51 PM |
Looks good got in $$$ | INFINITI | investorshub | 06/08/2022 12:24:21 PM |
Positive news out and Idiot manipulators trying to | trendzone | investorshub | 05/31/2022 1:10:29 PM |
Stealth BioTherapeutics Announces Data from the Phase 2 | conix | investorshub | 05/23/2022 4:57:57 PM |
znewcar1: MITO 31% v77M c..25 f59,9M H.379 bear trap | znewcar1 | investorshangout | 05/13/2022 2:59:19 AM |
Nice | INFINITI | investorshub | 05/12/2022 8:17:19 PM |
Added a good chunk here. | Skipman6 | investorshub | 05/12/2022 6:08:52 PM |
Stealth Biotherapeutics ($MITO) Gets a Buy Rating from | INFINITI | investorshub | 05/12/2022 4:35:11 PM |
Added some | INFINITI | investorshub | 05/12/2022 2:58:22 PM |
Added some | Triple nickle | investorshub | 05/12/2022 2:21:52 PM |
Took some 28s on pullback see if it | PStockPickz | investorshub | 05/12/2022 12:35:58 PM |
Might be a strong open let's see! | PStockPickz | investorshub | 05/12/2022 12:27:37 PM |
News | Awl416 | investorshub | 05/12/2022 11:41:11 AM |
A little too stealth? | KeepOn | investorshub | 01/17/2022 2:33:46 AM |
Anyone have insight into anything new here? | Nacho15 | investorshub | 06/30/2021 8:06:17 PM |
Great day and great NEWS. | boston127 | investorshub | 06/03/2021 4:46:15 AM |
* * $MITO Video Chart 06-02-2021 * * | ClayTrader | investorshub | 06/02/2021 9:09:50 PM |
News, Short Squeeze, Breakout and More Instantly...
Stealth BioTherapeutics Corp. Company Name:
MITO Stock Symbol:
NYSE Market:
Stealth BioTherapeutics Corp Announces Completion of Merger PR Newswire BOSTON , Nov. 16, 2022 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO) (the "Company" or "Stealth BioTherapeutics"), a clinical-stage biotechnology company focused on the ...
Stealth BioTherapeutics Announces SBT-272 Data Updates and Orphan Drug Designation for the Treatment of Amyotrophic Lateral Sclerosis (ALS) PR Newswire SBT-272 Phase 1 safety and tolerability data support further clinical development SBT-272 was neuroprotective...
Stealth BioTherapeutics Corp to Hold Extraordinary General Meeting of Shareholders PR Newswire BOSTON , Oct. 7, 2022 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO) ("Stealth" or the "Company"), a clinical-stage biotechnology company focused o...